首页> 美国卫生研究院文献>PLoS Clinical Trials >Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR
【2h】

Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR

机译:数字PCR检测流感与呼吸道合胞病毒负荷的临床相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute respiratory tract infections are a major cause of respiratory morbidity and mortality in pediatric patients worldwide. However, accurate viral and immunologic markers to predict clinical outcomes of this patient population are still lacking. Droplet digital PCR assays for influenza and respiratory syncytial virus (RSV) were designed and performed in 64 respiratory samples from 23 patients with influenza virus infection and 73 samples from 19 patients with RSV infection. Samples of patients with hematologic malignancies, solid tumors, or sickle cell disease were included. Clinical information from institutional medical records was reviewed to assess disease severity. Samples from patients with fever or respiratory symptoms had a significantly higher viral loads than those from asymptomatic patients. Samples from patients with influenza virus and RSV infection collected at presentation had significantly higher viral loads than those collected from patients after completing a course of oseltamivir or ribavirin, respectively. RSV loads correlated positively with clinical symptoms in patients ≤5 years of age, whereas influenza viral loads were associated with clinical symptoms, irrespective of age. Patients receiving antivirals for influenza and RSV had a significant reduction in viral loads after completing therapy. Digital PCR offers an effective method to monitor the efficacy of antiviral treatment for respiratory tract infections in immunocompromised hosts.
机译:急性呼吸道感染是全世界儿科患者呼吸道疾病和死亡的主要原因。然而,仍然缺乏准确的病毒和免疫标志物来预测该患者群体的临床结果。设计并对23例流感病毒感染患者的64个呼吸道样本和19例RSV感染患者的73个样本进行了针对流感和呼吸道合胞病毒(RSV)的液滴数字PCR检测并进行了分析。包括血液系统恶性肿瘤,实体瘤或镰状细胞病患者的样本。审查了来自机构病历的临床信息以评估疾病的严重程度。与无症状患者相比,发烧或呼吸道症状患者的样本病毒载量明显更高。在演示中收集的流感病毒和RSV感染患者的样品分别比完成一个疗程的奥司他韦或利巴韦林的患者的病毒载量高得多。 ≤5岁患者的RSV负荷与临床症状呈正相关,而流感病毒负荷与年龄,年龄无关。接受流感和RSV抗病毒药物治疗的患者在完成治疗后的病毒载量显着降低。数字PCR提供了一种有效的方法,可监测免疫受损宿主中抗病毒治疗呼吸道感染的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号